These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 10843685)
1. M cell-targeted DNA vaccination. Wu Y; Wang X; Csencsits KL; Haddad A; Walters N; Pascual DW Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9318-23. PubMed ID: 11459939 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Efficacy of Delta-Like Ligand 4 Gene Vaccine Overexpression on Liver Cancer in Mice. Yu Y; Zhao Y; Zhou G; Wang X Technol Cancer Res Treat; 2020; 19():1533033820942205. PubMed ID: 33191858 [TBL] [Abstract][Full Text] [Related]
3. Polyethylenimine-based micro/nanoparticles as vaccine adjuvants. Shen C; Li J; Zhang Y; Li Y; Shen G; Zhu J; Tao J Int J Nanomedicine; 2017; 12():5443-5460. PubMed ID: 28814862 [TBL] [Abstract][Full Text] [Related]
4. Recent trends on hydrogel based drug delivery systems for infectious diseases. Vashist A; Kaushik A; Vashist A; Jayant RD; Tomitaka A; Ahmad S; Gupta YK; Nair M Biomater Sci; 2016 Oct; 4(11):1535-1553. PubMed ID: 27709137 [TBL] [Abstract][Full Text] [Related]
5. Self-enhanced targeted delivery of a cell wall- and membrane-active antibiotics, daptomycin, against staphylococcal pneumonia. Jiang H; Xiong M; Bi Q; Wang Y; Li C Acta Pharm Sin B; 2016 Jul; 6(4):319-28. PubMed ID: 27471672 [TBL] [Abstract][Full Text] [Related]
6. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. Gandhi NS; Tekade RK; Chougule MB J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288 [TBL] [Abstract][Full Text] [Related]
14. Metabolic biotinylation of recombinant proteins in mammalian cells and in mice. Parrott MB; Barry MA Mol Ther; 2000 Jan; 1(1):96-104. PubMed ID: 10933917 [TBL] [Abstract][Full Text] [Related]
15. Genetic immunization with lung-targeting macroaggregated polyethyleneimine-albumin conjugates elicits combined systemic and mucosal immune responses. Orson FM; Kinsey BM; Hua PJ; Bhogal BS; Densmore CL; Barry MA J Immunol; 2000 Jun; 164(12):6313-21. PubMed ID: 10843685 [TBL] [Abstract][Full Text] [Related]
16. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex. Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387 [TBL] [Abstract][Full Text] [Related]
17. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses. Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800 [TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. Klavinskis LS; Barnfield C; Gao L; Parker S J Immunol; 1999 Jan; 162(1):254-62. PubMed ID: 9886393 [TBL] [Abstract][Full Text] [Related]
19. Intradermal naked plasmid DNA immunization: mechanisms of action. Elnekave M; Furmanov K; Hovav AH Expert Rev Vaccines; 2011 Aug; 10(8):1169-82. PubMed ID: 21854310 [TBL] [Abstract][Full Text] [Related]